Destiny Pharma PLC
LSE:DEST
Balance Sheet
Balance Sheet Decomposition
Destiny Pharma PLC
Current Assets | 10.7m |
Cash & Short-Term Investments | 9.8m |
Receivables | 663.1k |
Other Current Assets | 176.8k |
Non-Current Assets | 2.4m |
PP&E | 21.6k |
Intangibles | 2.3m |
Current Liabilities | 1.1m |
Accounts Payable | 1.1m |
Balance Sheet
Destiny Pharma PLC
Dec-2014 | Dec-2015 | Dec-2016 | Dec-2017 | Dec-2018 | Dec-2019 | Dec-2020 | Dec-2021 | Dec-2022 | ||
---|---|---|---|---|---|---|---|---|---|---|
Assets | ||||||||||
Cash & Cash Equivalents |
2
|
1
|
1
|
12
|
7
|
7
|
10
|
5
|
5
|
|
Cash |
2
|
1
|
1
|
12
|
7
|
7
|
10
|
5
|
2
|
|
Cash Equivalents |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
3
|
|
Short-Term Investments |
0
|
0
|
0
|
5
|
5
|
0
|
0
|
0
|
0
|
|
Total Receivables |
0
|
0
|
0
|
0
|
1
|
1
|
1
|
1
|
1
|
|
Other Current Assets |
0
|
0
|
0
|
0
|
0
|
0
|
1
|
0
|
0
|
|
Total Current Assets |
2
|
1
|
2
|
17
|
13
|
9
|
11
|
6
|
7
|
|
PP&E Net |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
PP&E Gross |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
Accumulated Depreciation |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
Intangible Assets |
0
|
0
|
0
|
0
|
0
|
0
|
2
|
2
|
2
|
|
Total Assets |
2
N/A
|
1
-45%
|
2
+26%
|
17
+905%
|
13
-24%
|
9
-34%
|
14
+60%
|
8
-40%
|
9
+6%
|
|
Liabilities | ||||||||||
Accounts Payable |
0
|
0
|
0
|
0
|
0
|
1
|
1
|
0
|
0
|
|
Accrued Liabilities |
0
|
0
|
0
|
0
|
0
|
0
|
1
|
1
|
1
|
|
Short-Term Debt |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
Total Current Liabilities |
0
|
0
|
0
|
0
|
1
|
1
|
1
|
1
|
1
|
|
Long-Term Debt |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
Total Liabilities |
0
N/A
|
0
-79%
|
0
+64%
|
0
+157%
|
1
+102%
|
1
0%
|
1
+59%
|
1
-39%
|
1
+51%
|
|
Equity | ||||||||||
Common Stock |
0
|
0
|
0
|
0
|
0
|
0
|
1
|
1
|
1
|
|
Retained Earnings |
15
|
16
|
17
|
1
|
5
|
10
|
15
|
20
|
26
|
|
Additional Paid In Capital |
17
|
17
|
18
|
17
|
17
|
17
|
27
|
27
|
33
|
|
Total Equity |
2
N/A
|
1
-37%
|
2
+23%
|
17
+980%
|
12
-27%
|
8
-37%
|
12
+60%
|
8
-40%
|
8
+2%
|
|
Total Liabilities & Equity |
2
N/A
|
1
-45%
|
2
+26%
|
17
+905%
|
13
-24%
|
9
-34%
|
14
+60%
|
8
-40%
|
9
+6%
|
|
Shares Outstanding | ||||||||||
Common Shares Outstanding |
42
|
42
|
42
|
44
|
44
|
44
|
60
|
60
|
73
|